Age-Related Cardiac Dysfunction is Associated with Enhanced Oxidative Stress in Senescence-Prone Mice
Joshua D. Lovelock,Atsuko Tanaka,Lihong Cheng,Torahiro Matsuda,Zhe Jiao,Qianhong Qin,Alana L. Reed,Brain H. Crawford,Mary B. Wagner,Roy L. Sutliff,Dan Sorescu
DOI: https://doi.org/10.1016/j.cardfail.2010.06.122
IF: 6.592
2010-01-01
Journal of Cardiac Failure
Abstract:Advanced age is identified as a significant risk factor for cardiovascular disease. Age-related cardiac remodeling is characterized by cardiomyocyte loss, hypertrophy, and fibrosis leading to diastolic and systolic dysfunction. We used the senescence-accelerated mouse (SAM) model to investigate age-related cardiac dysfunction and the role of oxidative stress. Echocardiography performed on 11 month old senescence-prone (SAMP) and senescence-resistant control mice (SAMR) showed that fractional shortening was signifiantly reduced (37.3% ± 3 vs. 29.9% ± 3; n = 8, p < 0.02). The end-diastolic diamter and end-systolic diameter significantly increased in the SAMP mice (EDD, 0.36 vs. 0.41 mm, p < 0.05; ESD, 0.23 vs. 0.29 mm, p < 0.01) consistent with cardiac remodeling. Cardiomyocytes were isolated and paced at increasing frequencies (0.25, 0.5, 1, 2, 3 Hz). SAMP cardiomyocytes had a significant decrease in fractional shortening at higher frequencies (n = 10, p < 0.001) compared to an increase in SAMR controls. The rate of contraction was significantly slower in SAMP cardiomyocytes (n = 10, p < 0.01). Calcium transients were evaluated to elucidate the mechanisms leading to cardiac dysfunction and the rate to 90% peak calcium was decreased in SAMP myocytes (n = 10, p < 0.01). SAMP myocytes had a 5-6 fold increase in expression of fetal phenotype markers β-MHC and ANF (n = 5, p < 0.05). Likewise, expression of senescence markers p16 and p19 were increase 50% and 300% respectively (n = 7, p < 0.05). Histological sections from SAMP hearts showed a 2-fold increase in 8-oxoguanine staining consistent with enhanced oxidized DNA and cumulative oxidative stress (n = 4, p < 0.01). This correlated with a 2-3 fold enhanced expression of NADPH oxidases (Nox) 2 and 4 (n = 5, p < 0.05), but antioxidant enzymes superoxide dismutase, catalase, and peroxiredoxin3 were unchanged. FoxO3A, an oxidant-sensitive transcription factor was upregulated 30-fold in SAMP cardiomyocytes (n = 5, p < 0.01). Similarly, atrogin-1, a downstream effector of FoxO3A and essential component of the ubiquitin-ligase complex was increased 9-fold in SAMP cardiomyocytes (n = 5, p < 0.05). Taken together, these data indicate that age-related cardiac remodeling and dysfunction is associated with an increase in oxidative stress and up-regulation of Nox2 and Nox4 without a corresponding increase in antioxidant enzymes. Additionally, Nox2 and Nox4 may be modulating oxidant stress through a FoxO3A/atrogin-1 pathway. Advanced age is identified as a significant risk factor for cardiovascular disease. Age-related cardiac remodeling is characterized by cardiomyocyte loss, hypertrophy, and fibrosis leading to diastolic and systolic dysfunction. We used the senescence-accelerated mouse (SAM) model to investigate age-related cardiac dysfunction and the role of oxidative stress. Echocardiography performed on 11 month old senescence-prone (SAMP) and senescence-resistant control mice (SAMR) showed that fractional shortening was signifiantly reduced (37.3% ± 3 vs. 29.9% ± 3; n = 8, p < 0.02). The end-diastolic diamter and end-systolic diameter significantly increased in the SAMP mice (EDD, 0.36 vs. 0.41 mm, p < 0.05; ESD, 0.23 vs. 0.29 mm, p < 0.01) consistent with cardiac remodeling. Cardiomyocytes were isolated and paced at increasing frequencies (0.25, 0.5, 1, 2, 3 Hz). SAMP cardiomyocytes had a significant decrease in fractional shortening at higher frequencies (n = 10, p < 0.001) compared to an increase in SAMR controls. The rate of contraction was significantly slower in SAMP cardiomyocytes (n = 10, p < 0.01). Calcium transients were evaluated to elucidate the mechanisms leading to cardiac dysfunction and the rate to 90% peak calcium was decreased in SAMP myocytes (n = 10, p < 0.01). SAMP myocytes had a 5-6 fold increase in expression of fetal phenotype markers β-MHC and ANF (n = 5, p < 0.05). Likewise, expression of senescence markers p16 and p19 were increase 50% and 300% respectively (n = 7, p < 0.05). Histological sections from SAMP hearts showed a 2-fold increase in 8-oxoguanine staining consistent with enhanced oxidized DNA and cumulative oxidative stress (n = 4, p < 0.01). This correlated with a 2-3 fold enhanced expression of NADPH oxidases (Nox) 2 and 4 (n = 5, p < 0.05), but antioxidant enzymes superoxide dismutase, catalase, and peroxiredoxin3 were unchanged. FoxO3A, an oxidant-sensitive transcription factor was upregulated 30-fold in SAMP cardiomyocytes (n = 5, p < 0.01). Similarly, atrogin-1, a downstream effector of FoxO3A and essential component of the ubiquitin-ligase complex was increased 9-fold in SAMP cardiomyocytes (n = 5, p < 0.05). Taken together, these data indicate that age-related cardiac remodeling and dysfunction is associated with an increase in oxidative stress and up-regulation of Nox2 and Nox4 without a corresponding increase in antioxidant enzymes. Additionally, Nox2 and Nox4 may be modulating oxidant stress through a FoxO3A/atrogin-1 pathway.